| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.12B | 14.65B | 13.13B | 12.38B | 11.80B | 11.85B |
| Gross Profit | 14.77B | 13.88B | 12.93B | 12.15B | 11.49B | 11.53B |
| EBITDA | 2.14B | 2.65B | 2.31B | 2.48B | 2.04B | 2.30B |
| Net Income | 1.29B | 1.31B | 1.06B | 1.04B | 891.00M | 996.00M |
Balance Sheet | ||||||
| Total Assets | 1.11T | 1.11T | 1.15T | 1.10T | 1.11T | 1.09T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 93.27B | 124.76B | 72.58B | 99.52B | 96.63B |
| Total Debt | 24.05B | 24.06B | 42.06B | 42.06B | 63.76B | 63.76B |
| Total Liabilities | 1.07T | 1.06T | 1.10T | 1.05T | 1.06T | 1.04T |
| Stockholders Equity | 48.68B | 47.99B | 49.90B | 47.77B | 48.67B | 49.34B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.33B | -2.65B | -38.59B | 11.43B | 29.26B |
| Operating Cash Flow | 0.00 | -3.98B | -1.71B | -38.20B | 12.00B | 29.46B |
| Investing Cash Flow | 0.00 | 6.61B | -4.00B | 11.73B | -8.65B | -17.48B |
| Financing Cash Flow | 0.00 | -22.53B | 48.96B | -471.00M | -467.00M | -467.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥23.65B | 7.08 | ― | 3.50% | 16.60% | -5.51% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥18.60B | 4.85 | ― | 3.37% | 3.70% | 24.98% | |
66 Neutral | ¥12.22B | 21.28 | ― | 2.68% | 5.57% | -23.26% | |
66 Neutral | ¥12.91B | 7.04 | ― | 3.74% | 5.91% | 5.03% | |
64 Neutral | ¥15.96B | 4.33 | ― | 3.30% | 11.93% | 36.32% | |
53 Neutral | ¥12.66B | 8.11 | ― | 1.89% | 8.11% | 68.98% |